caffeine and oxidopamine

caffeine has been researched along with oxidopamine in 47 studies

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-19909 (19.15)18.7374
1990's8 (17.02)18.2507
2000's19 (40.43)29.6817
2010's10 (21.28)24.3611
2020's1 (2.13)2.80

Authors

AuthorsStudies
Glen, RC; Lowe, R; Mitchell, JB1
Finn, IB; Holtzman, SG; Iuvone, PM1
Carey, RJ1
French, ED1
Erinoff, L; Snodgrass, SR1
Branch, RA; Holycross, B; Jackson, EK; Li, P; Ohnishi, A1
Koley, BN; Koley, J; Saha, JK1
Casas, M; Herrera-Marschitz, M; Ungerstedt, U1
French, ED; Vantini, G1
Basura, M; Erinoff, L; Kelly, PH; Snodgrass, SR1
Joyce, EM; Koob, GF1
Schiffmann, SN; Vanderhaeghen, JJ1
Reid, A; Sawynok, J1
Ferré, S; Fuxe, K; Giménez-Llort, L; Martínez, E; Pezzola, A; Popoli, P; Reggio, R1
Fenu, S; Morelli, M1
Barbanoj, M; Casas, M; Jané, F; Kulisevsky, J; Prat, G; Robledo, P3
Barbanoj, M; Casas, M; Jané, F; Prat, G; Rubio, A1
Barbanoj, M; Casas, M; Jané, F; Prat, G; Robledo, P; Rubio, A1
Dassesse, D; Ledent, C; Meunier, JC; Parmentier, M; Schiffmann, SN1
Cauli, O; Morelli, M; Pinna, A; Valentini, V1
Amalric, M; Breysse, N; Coccurello, R1
Casas, M; Núñez-Taltavull, JF; Prat, G; Robledo, P; Rubio, A1
Cauli, O; Morelli, M1
Bové, J; Cortés, R; Marin, C; Mengod, G; Serrats, J; Tolosa, E1
Friedman, MI; Stricker, EM; Zigmond, MJ; Zimmerman, MB1
Chen, JF; Schwarzschild, MA; Yu, L1
Cauli, O; Morelli, M; Pinna, A1
Aguilar, E; Bové, J; Cortés, R; Marin, C; Mengod, G; Serrats, J1
Aguiar, LM; Cunha, GM; Freitas, RM; Macêdo, DS; Nobre, HV; Oliveira, AA; Sousa, FC; Vasconcelos, SM; Viana, GS1
Morelli, M; Pinna, A; Simola, N; Tronci, E1
Barbanoj, M; Kulisevsky, J; Pérez, V; Rodríguez-Alvarez, J; Rubio, A; Sosti, V1
Aguiar, LM; de Sousa, FC; Macêdo, DS; Oliveira, AA; Vasconcelos, SM; Viana, GS1
Kelsey, JE; Langelier, NA; Oriel, BS; Reedy, C1
Ba, M; Kong, M; Liu, Z; Ma, Y; Song, L1
Chen, JF; Herm, L; Kalda, A; Rinken, A; Zharkovsky, A1
Cunha, GM; de Moraes, MO; de Vasconcelos, LM; Leal, LK; Magalhães, HI; Maia, FD; Nobre, HV; Oliveira Neto, RN; Viana, GS1
Dimitrov, KD; Drake, JD; Pollack, AE1
Burdett, TC; Cassin, JJ; Chen, JF; Fredholm, BB; Healy, B; Schwarzschild, MA; Xiao, D1
Ahern, S; Caballero, M; Carbonell, L; Ciruela, F; Cuffí, ML; Fernández-Dueñas, V; Núñez, F; Sánchez, S1
Dziubina, A; Gołembiowska, K1
Acuña-Lizama, MM; Alvarez-Cervera, FJ; Bata-García, JL; Góngora-Alfaro, JL1
Cavalheiro, EA; Cerqueira, GS; Correia, AO; de Barros Viana, GS; de Castro Brito, GA; Machado-Filho, JA; Montenegro, AB; Naffah-Mazzacoratti, Mda G; Neves, KR; Nobre, ME1
Mahmoudi, J; Reyhani-Rad, S1
Haining, RL; Hernandez, A; Jones, TM1
Abuhamdah, SM; Abuirmeileh, AN; Alzoubi, KH; Ashraf, A1

Reviews

1 review(s) available for caffeine and oxidopamine

ArticleYear
Caffeine and the dopaminergic system.
    Behavioural pharmacology, 2005, Volume: 16, Issue:2

    Topics: Adrenergic Agents; Animals; Behavior; Caffeine; Central Nervous System Stimulants; Drug Interactions; Humans; Motor Activity; Oxidopamine; Rats; Receptor, Adenosine A2A; Receptors, Dopamine; Reinforcement, Psychology

2005

Other Studies

46 other study(ies) available for caffeine and oxidopamine

ArticleYear
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
    Neuropharmacology, 1990, Volume: 29, Issue:7

    Topics: alpha-Methyltyrosine; Animals; Brain Chemistry; Caffeine; Catecholamines; Dextroamphetamine; Diencephalon; Dopamine; Dose-Response Relationship, Drug; Hydroxydopamines; Male; Methylphenidate; Methyltyrosines; Motor Activity; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Reserpine; Telencephalon; Tyrosine 3-Monooxygenase

1990
Antiparkinsonian effects of caffeine depend upon pavlovian drug conditioning processes.
    Brain research, 1990, Jun-04, Volume: 518, Issue:1-2

    Topics: Animals; Apomorphine; Caffeine; Conditioning, Classical; Functional Laterality; Hydroxydopamines; Male; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Rotation; Substantia Nigra

1990
Effects of N-allylnormetazocine (SKF 10,047), phencyclidine, and other psychomotor stimulants in the rat following 6-hydroxydopamine lesion of the ventral tegmental area.
    Neuropharmacology, 1986, Volume: 25, Issue:4

    Topics: Amphetamine; Animals; Apomorphine; Caffeine; Central Nervous System Stimulants; Dopamine; Hydroxydopamines; Male; Motor Activity; Oxidopamine; Phenazocine; Phencyclidine; Rats; Rats, Inbred Strains; Scopolamine; Tegmentum Mesencephali

1986
Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
    Pharmacology, biochemistry, and behavior, 1986, Volume: 24, Issue:4

    Topics: 5,7-Dihydroxytryptamine; Age Factors; Animals; Animals, Newborn; Biogenic Amines; Brain Chemistry; Caffeine; Dihydroxytryptamines; Drug Interactions; Hydroxydopamines; Motor Activity; Norepinephrine; Oxidopamine; Rats; Serotonin

1986
Caffeine enhances the slow-pressor response to angiotensin II in rats. Evidence for a caffeine-angiotensin II interaction with the sympathetic nervous system.
    The Journal of clinical investigation, 1987, Volume: 80, Issue:1

    Topics: Angiotensin II; Animals; Blood Pressure; Caffeine; Drug Interactions; Hydroxydopamines; Male; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Sympathectomy, Chemical; Sympathetic Nervous System

1987
Effects of nicotine on spontaneous contractions of isolated atria of toad (Bufo melanostictus).
    Archives internationales de pharmacodynamie et de therapie, 1987, Volume: 288, Issue:1

    Topics: Animals; Atropine; Bufonidae; Caffeine; Edetic Acid; Hemicholinium 3; Hexamethonium Compounds; Hydroxydopamines; In Vitro Techniques; Myocardial Contraction; Nicotine; Oxidopamine; Physostigmine; Tyramine; Verapamil

1987
Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses.
    Psychopharmacology, 1988, Volume: 94, Issue:1

    Topics: Animals; Apomorphine; Caffeine; Corpus Striatum; Denervation; Dopamine; Dose-Response Relationship, Drug; Hydroxydopamines; Injections, Intraventricular; Kainic Acid; Male; Oxidopamine; Rats; Rats, Inbred Strains; Rotation; Stereotyped Behavior; Substantia Nigra

1988
Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants.
    Psychopharmacology, 1984, Volume: 82, Issue:1-2

    Topics: Animals; Caffeine; Central Nervous System Stimulants; Dextroamphetamine; Hydroxydopamines; Motor Activity; Nucleus Accumbens; Oxidopamine; Phenazocine; Phencyclidine; Rats; Receptors, Dopamine; Scopolamine; Septal Nuclei

1984
Six-hydroxydopamine induced hyperactivity: neither sex differences nor caffeine stimulation are found.
    Pharmacology, biochemistry, and behavior, 1984, Volume: 20, Issue:5

    Topics: Aging; alpha-Methyltyrosine; Animals; Body Weight; Brain; Brain Chemistry; Caffeine; Catecholamines; Choline O-Acetyltransferase; Enzymes; Female; Glutamate Decarboxylase; Hydroxydopamines; Male; Methyltyrosines; Motor Activity; Oxidopamine; Pimozide; Pregnancy; Rats; Sex Characteristics

1984
Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
    Psychopharmacology, 1981, Volume: 73, Issue:4

    Topics: Animals; Apomorphine; Caffeine; Dextroamphetamine; Hydroxydopamines; Locomotion; Male; Nucleus Accumbens; Oxidopamine; Rats; Receptors, Dopamine; Scopolamine; Septal Nuclei

1981
Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1993, Volume: 13, Issue:3

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Corpus Striatum; Enkephalins; Gene Expression Regulation; Globus Pallidus; Neurons; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Purinergic; Substance P; Substantia Nigra

1993
Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:2

    Topics: 5,7-Dihydroxytryptamine; Analgesia; Animals; Brain; Caffeine; Central Nervous System Stimulants; Dopamine; Formaldehyde; Male; Motor Activity; Norepinephrine; Oxidopamine; Rats; Rats, Sprague-Dawley; Serotonin

1996
Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents.
    Neuroscience letters, 1996, Nov-08, Volume: 218, Issue:3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic Agents; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Locomotion; Male; Mice; Mice, Inbred Strains; Motor Activity; Motor Neurons; Oxidopamine; Purinergic P1 Receptor Antagonists; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sympatholytics; Theophylline

1996
Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors.
    The European journal of neuroscience, 1998, Volume: 10, Issue:5

    Topics: Animals; Apomorphine; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Male; Motor Activity; Oxidopamine; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Stimulation, Chemical; Triazoles; Xanthines

1998
Scopolamine prevents tolerance to the effects of caffeine on rotational behavior in 6-hydroxydopamine-denervated rats.
    European journal of pharmacology, 1999, Jan-29, Volume: 366, Issue:1

    Topics: Animals; Caffeine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Tolerance; Functional Laterality; Male; Muscarinic Antagonists; N-Methylscopolamine; Nerve Degeneration; Oxidopamine; Parasympatholytics; Rats; Rats, Sprague-Dawley; Scopolamine; Sodium Chloride; Stereotyped Behavior

1999
Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 9, Issue:6

    Topics: Adrenergic Agents; Animals; Behavior, Animal; Bromocriptine; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Drug Therapy, Combination; Drug Tolerance; Male; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinson Disease; Rats

1999
Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats.
    European journal of pharmacology, 2000, May-19, Volume: 396, Issue:2-3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Caffeine; Dopamine Agonists; Drug Synergism; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Rotation

2000
Effects of sub-chronic combined treatment with pergolide and caffeine on contralateral rotational behavior in unilateral 6-hydroxydopamine-denervated rats.
    Brain research, 2000, Jun-23, Volume: 868, Issue:2

    Topics: Animals; Bromocriptine; Caffeine; Denervation; Drug Administration Schedule; Drug Combinations; Drug Tolerance; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Rats; Rats, Sprague-Dawley; Rotation

2000
Methylxanthines reverse the adipsic and aphagic syndrome induced by bilateral 6-hydroxydopamine lesions of the nigrostriatal pathway in rats.
    Pharmacology, biochemistry, and behavior, 2000, Volume: 66, Issue:2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Caffeine; Corpus Striatum; Dextroamphetamine; Dopamine Agonists; Dopamine Antagonists; Drinking; Eating; Male; Neural Pathways; Oxidopamine; Quinpirole; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sulpiride; Syndrome; Theophylline; Xanthines

2000
Regulation of nociceptin mRNA expression in the septum by dopamine and adenosine systems.
    Neuroreport, 2000, Sep-28, Volume: 11, Issue:14

    Topics: Adenosine; Animals; Caffeine; Denervation; Dopamine; Dose-Response Relationship, Drug; Male; Mice; Mice, Knockout; Neural Pathways; Neurons; Nociceptin; Opioid Peptides; Oxidopamine; Receptor, Adenosine A2A; Receptors, Dopamine; Receptors, Purinergic P1; RNA, Messenger; Septal Nuclei; Stress, Physiological

2000
Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:10

    Topics: Amphetamine; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Dopamine; Drug Administration Schedule; Drug Interactions; Functional Laterality; Male; Motor Activity; Oxidopamine; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Stimulation, Chemical; Sympatholytics; Time Factors

2003
Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:8

    Topics: Adenosine A2 Receptor Antagonists; Animals; Brain; Caffeine; Conditioning, Operant; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Gene Expression Regulation; Genes, fos; Male; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Phosphoproteins; Phosphorylation; Psychomotor Performance; Pyridines; Rats; Reaction Time; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Sympatholytics

2004
Biphasic effects of oxotremorine-M on turning behavior induced by caffeine in 6-OHDA-lesioned rats.
    European journal of pharmacology, 2004, Dec-03, Volume: 506, Issue:1

    Topics: Analysis of Variance; Animals; Behavior, Animal; Caffeine; Dose-Response Relationship, Drug; Male; Muscarinic Agonists; Oxidopamine; Oxotremorine; Rats; Rats, Sprague-Dawley

2004
Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.
    Experimental brain research, 2005, Volume: 165, Issue:3

    Topics: Adenosine A2 Receptor Antagonists; Animals; Caffeine; Cell Count; Dynorphins; Enkephalins; Globus Pallidus; Immunohistochemistry; In Situ Hybridization; Male; Microinjections; Neostriatum; Neural Pathways; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; RNA, Messenger; Stereotyped Behavior; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase

2005
Caffeine restores feeding response to 2-deoxy-D-glucose in 6-hydroxydopamine-treated rats.
    Nature, 1977, May-12, Volume: 267, Issue:5607

    Topics: Animals; Blood Glucose; Body Weight; Caffeine; Deoxyglucose; Eating; Feeding Behavior; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; Theophylline; Xanthenes

1977
Cross-sensitization between caffeine- and L-dopa-induced behaviors in hemiparkinsonian mice.
    Neuroscience letters, 2006, Jan-23, Volume: 393, Issue:1

    Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Caffeine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Levodopa; Mice; Mice, Inbred C57BL; Oxidopamine; Parkinson Disease, Secondary; Random Allocation; Time Factors

2006
Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D(1) but not D(2) receptor agonists.
    Behavioural pharmacology, 2005, Volume: 16, Issue:8

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Caffeine; Central Nervous System Stimulants; Dopamine Agents; Dopamine Agonists; Levodopa; Male; Oxidopamine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Sympathectomy, Chemical; Sympatholytics

2005
Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats.
    Synapse (New York, N.Y.), 2006, Jun-01, Volume: 59, Issue:7

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenosine; Adrenergic Agents; Animals; Caffeine; Corpus Striatum; Dynorphins; Dyskinesias; Enkephalins; Immunohistochemistry; In Situ Hybridization; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; RNA, Messenger

2006
Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats.
    Pharmacology, biochemistry, and behavior, 2006, Volume: 84, Issue:3

    Topics: Animals; Apomorphine; Brain; Brain Diseases; Caffeine; Disease Models, Animal; Dopamine Agents; Male; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar

2006
Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats.
    Amino acids, 2006, Volume: 31, Issue:4

    Topics: Adrenergic Agents; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Dextroamphetamine; Male; Motor Activity; Oxidopamine; Rats; Rats, Sprague-Dawley; Sympatholytics

2006
Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
    European journal of pharmacology, 2007, Dec-08, Volume: 576, Issue:1-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Benzylamines; Brain; Caffeine; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Male; Motor Activity; Neurotoxins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley

2007
CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats.
    Brain research, 2008, Jan-29, Volume: 1191

    Topics: Adenosine A2 Receptor Agonists; Animals; Behavior, Animal; Biogenic Monoamines; Caffeine; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxyindoleacetic Acid; Lipid Peroxidation; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neostriatum; Neuroprotective Agents; Nitrites; Norepinephrine; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Receptors, Adenosine A2; Rotation; Serotonin

2008
The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat.
    Psychopharmacology, 2009, Volume: 201, Issue:4

    Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Caffeine; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Globus Pallidus; Injections; Levodopa; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Long-Evans

2009
Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats.
    Brain research, 2009, Jun-18, Volume: 1276

    Topics: Adenosine A2 Receptor Agonists; Animals; Antiparkinson Agents; Caffeine; Corpus Striatum; Dopamine and cAMP-Regulated Phosphoprotein 32; Levodopa; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Motor Activity; Movement; Oxidopamine; Parkinson Disease, Secondary; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Signal Transduction; Up-Regulation

2009
Co-administration of the partial dopamine D2 agonist terguride with L-dopa attenuates L-dopa-induced locomotor sensitization in hemiparkinsonian mice.
    Behavioural brain research, 2009, Sep-14, Volume: 202, Issue:2

    Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Benzazepines; Caffeine; Corpus Striatum; Dopamine Agonists; Drug Therapy, Combination; Guanosine 5'-O-(3-Thiotriphosphate); Levodopa; Lisuride; Male; Mice; Mice, Inbred C57BL; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Random Allocation; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulfur Radioisotopes

2009
Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells.
    Neurochemistry international, 2010, Volume: 56, Issue:1

    Topics: Adenosine A2 Receptor Agonists; Animals; Apoptosis; Caffeine; Cells, Cultured; Encephalitis; Female; Free Radicals; Inflammation Mediators; Lipid Peroxidation; Microglia; Nerve Degeneration; Neurons; Neuroprotective Agents; Nitrites; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Receptor, Adenosine A2A; Substantia Nigra; Sympatholytics; Xanthines

2010
Prior treatment (priming) with caffeine sensitizes D2-dopamine-mediated contralateral rotational behavior in 6-hydroxydopamine-lesioned rats.
    Pharmacology, 2010, Volume: 86, Issue:2

    Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Dose-Response Relationship, Drug; Functional Laterality; Male; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sympathectomy, Chemical; Sympatholytics; Time Factors

2010
Deletion of adenosine A₁ or A(₂A) receptors reduces L-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease.
    Brain research, 2011, Jan-07, Volume: 1367

    Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Caffeine; Corpus Striatum; Disease Models, Animal; Dynorphins; Dyskinesia, Drug-Induced; Enkephalins; Gene Expression Regulation; Levodopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidopamine; Parkinson Disease; Protein Precursors; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A1; Receptor, Adenosine A2A; RNA, Messenger; Statistics, Nonparametric; Time Factors

2011
Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD).
    Neuroscience letters, 2011, Apr-20, Volume: 494, Issue:1

    Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Caffeine; Central Nervous System Stimulants; Disease Models, Animal; Motor Activity; Oxidopamine; Rats

2011
Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats.
    Neurotoxicity research, 2012, Volume: 21, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Benserazide; Caffeine; Dopamine; Glutamic Acid; Hydroxyl Radical; Levodopa; Male; Microdialysis; Neostriatum; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Receptor, Adenosine A2A; Triazines; Triazoles

2012
Caffeine has greater potency and efficacy than theophylline to reverse the motor impairment caused by chronic but not acute interruption of striatal dopaminergic transmission in rats.
    Neuropharmacology, 2013, Volume: 70

    Topics: Animals; Caffeine; Catalepsy; Corpus Striatum; Dopaminergic Neurons; Dose-Response Relationship, Drug; Haloperidol; Male; Motor Skills; Oxidopamine; Parkinsonian Disorders; Rats; Theophylline

2013
Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
    Behavioural brain research, 2014, May-01, Volume: 264

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Apomorphine; Brain; Caffeine; Cytokines; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Exploratory Behavior; Histone Deacetylases; Male; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase

2014
Effect of adenosine A2A receptor antagonists on motor disorders induced by 6-hydroxydopamine in rat.
    Acta cirurgica brasileira, 2016, Volume: 31, Issue:2

    Topics: Adenosine A2 Receptor Antagonists; Animals; Caffeine; Disease Models, Animal; Hypokinesia; Male; Motor Activity; Motor Disorders; Oxidopamine; Parkinson Disease, Secondary; Purinergic P1 Receptor Antagonists; Rats, Wistar; Time and Motion Studies

2016
Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.
    Neurochemical research, 2016, Volume: 41, Issue:12

    Topics: Caffeine; Cysteine; Dopamine; Iron; Melanins; Nicotine; Oxidopamine; Parkinson Disease; Polymerization; Spectrometry, Fluorescence

2016
Protective effect of caffeine and/or taurine on the 6-hydroxydopamine-induced rat model of Parkinson's disease: Behavioral and neurochemical evidence.
    Restorative neurology and neuroscience, 2021, Volume: 39, Issue:2

    Topics: Animals; Apomorphine; Behavior, Animal; Caffeine; Corpus Striatum; Disease Models, Animal; Dopamine; Oxidopamine; Parkinson Disease; Rats; Taurine

2021